FREQUENCIES AND PROGNOSTIC IMPACT OF RAS MUTATIONS IN MLL-REARRANGED ACUTE LYMPHOBLASTIC LEUKEMIA IN INFANTS

被引：0
|
作者：
Driessen, Emma M. C. [1 ]
van Roon, Eddy H. J. [1 ]
Spijkers-Hagelstein, Jill A. P. [1 ]
Schneider, Pauline [1 ]
de Lorenzo, Paola [2 ]
Valsecchi, Maria Grazia [2 ]
Pieters, Rob [1 ]
Stam, Ronald W. [1 ]
机构：
[1] Erasmus MC Sophia Childrens Hosp, Rotterdam, Netherlands
[2] Univ Milano Bicocca, Monza, Italy
来源：
PEDIATRIC BLOOD & CANCER | 2012年 / 59卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1005 / 1005
页数：1
相关论文
共 50 条
  • [1] FREQUENCIES AND PROGNOSTIC IMPACT OF RAS MUTATIONS IN MLL-REARRANGED ACUTE LYMPHOBLASTIC LEUKEMIA IN INFANTS
    Driessen, E.
    van Roon, E.
    Spijkers-Hagelstein, J.
    Schneider, P.
    de Lorenzo, P.
    Valsecchi, M.
    Pieters, R.
    Stam, R.
    HAEMATOLOGICA, 2012, 97 : 4 - 4
  • [2] Frequencies and prognostic impact of RAS mutations in MLL-rearranged acute lymphoblastic leukemia in infants
    Driessen, Emma M. C.
    van Roon, Eddy H. J.
    Spijkers-Hagelstein, Jill A. P.
    Schneider, Pauline
    de Lorenzo, Paola
    Valsecchi, Maria Grazia
    Pieters, Rob
    Stam, Ronald W.
    HAEMATOLOGICA, 2013, 98 (06) : 937 - 944
  • [3] MLL-Rearranged Acute Lymphoblastic Leukemia
    Firas El Chaer
    Michael Keng
    Karen K. Ballen
    Current Hematologic Malignancy Reports, 2020, 15 : 83 - 89
  • [4] MLL-Rearranged Acute Lymphoblastic Leukemia
    El Chaer, Firas
    Keng, Michael
    Ballen, Karen K.
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2020, 15 (02) : 83 - 89
  • [5] Unravelling the Mirnome of MLL-Rearranged Acute Lymphoblastic Leukemia
    Castro, Patricia Garrido
    Bueno, Clara
    van Roon, Eddy H. J.
    Pinhancos, Sandra S. Mimoso
    Schneider, Pauline
    Willekes, Merel
    Menendez, Pablo
    Pieters, Rob
    Stam, Ronald
    BLOOD, 2014, 124 (21)
  • [6] High incidence of RAS signalling pathway mutations in MLL-rearranged acute myeloid leukemia
    V Grossmann
    S Schnittger
    F Poetzinger
    A Kohlmann
    A Stiel
    C Eder
    A Fasan
    W Kern
    T Haferlach
    C Haferlach
    Leukemia, 2013, 27 : 1933 - 1936
  • [7] High incidence of RAS signalling pathway mutations in MLL-rearranged acute myeloid leukemia
    Grossmann, V.
    Schnittger, S.
    Poetzinger, F.
    Kohlmann, A.
    Stiel, A.
    Eder, C.
    Fasan, A.
    Kern, W.
    Haferlach, T.
    Haferlach, C.
    LEUKEMIA, 2013, 27 (09) : 1933 - 1936
  • [8] Constitutive Activation of FLT3 Is a Positive Prognostic Factor in Infants with MLL-Rearranged Acute Lymphoblastic Leukemia
    Fedders, Henning
    Schewe, Denis Martin
    Zimmermann, Martin
    Alsadeq, Ameera
    Moericke, Anja
    zur Stadt, Udo
    Horstmann, Martin A.
    Pieters, Rob
    Schrappe, Martin
    Cario, Gunnar
    Stanulla, Martin
    BLOOD, 2015, 126 (23)
  • [9] MEK inhibition is a promising therapeutic strategy for MLL-rearranged infant acute lymphoblastic leukemia patients carrying RAS mutations
    Kerstjens, Mark
    Driessen, Emma M. C.
    Willekes, Merel
    Pinhancos, Sandra S.
    Schneider, Pauline
    Pieters, Rob
    Stam, Ronald W.
    ONCOTARGET, 2017, 8 (09) : 14835 - 14846
  • [10] Bet Inhibition as a Novel Therapeutic Approach for the Treatment of MLL-Rearranged Acute Lymphoblastic Leukemia in Infants
    Bardini, M.
    Trentin, L.
    Rizzo, F.
    Vieri, M.
    Savino, A. M.
    Fazio, G.
    Geertruy, T. K.
    Basso, G.
    Cazzaniga, G.
    Biondi, A.
    PEDIATRIC BLOOD & CANCER, 2016, 63 : S101 - S101
12345